The following biotech stocks featured on our website reached new highs on Friday (Dec.8, 2023). Were these stocks part of your investment portfolio?
*Last Closing Price refers to the closing price of the stock on Dec.8, 2023.
Ticker
Published Date
Published Price
Maximum Price Since Publication
*Last Closing Price
Maximum Gain %
Scholar Rock Holding Corp. (SRRK)
Sep.27, 2023
$6.76
$19.52
$18.25
188%
ALX Oncology Holdings Inc. (ALXO)
Sep.18, 2023
$5.24
$13.50
$12.26
157%
Applied Therapeutics Inc. (APLT)
May 8, 2023
$1.66
$3.36
$3.11
102%
Disc Medicine, Inc. (IRON)
Jan.23, 2023
$21.30
$63.25
$61.01
196%
CVRx, Inc. (CVRX)
Jan.30, 2023
$14.87
$24.81
$24.15
66%
Innoviva Inc. (INVA)
Apr.19, 2023
$11.34
$15.14
$15.12
33%
RxSight, Inc. (RXST)
Jul.10, 2023
$31.30
$35.04
$34.97
12%
Alpine Immune Sciences, Inc. (ALPN)
Mar.3, 2023
$7.97
$17.25
$16.84
116%
Intensity Therapeutics, Inc. (INTS)
Dec.7, 2023
$3.35
$11.44
$6.88
241%
Jin Medical International Ltd. (ZJYL)
Sep.25, 2023
$17.95
$30.45
$27.50
69%
Savara Inc. (SVRA)
June 2, 2023
$2.93
$4.26
$4.16
45%
Medpace Holdings, Inc. (MEDP)
Apr.25, 2023
$225
$289.14
$283.19
28%
Augmedix, Inc. (AUGX)
$3.65
$6.00
$5.97
64%
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.